WADA Prohibited List - Section S0 Unapproved Substances (BPC-157, TB-500 categorization)
Representative Literature The following peer-reviewed publications reflect independent academic and preclinical research into the BPC-157 peptide sequence generally
Tesamorelin is FDA-approved as Egrifta for visceral fat reduction in HIV lipodystrophy, and Sermorelin held a past FDA approval before being discontinued for business reasons
Researchers continue to investigate these mechanisms, and additional work is needed to better understand how they function in different experimental models
J Orthop Res 2003 Nov;21(6):976-83 8] Sven Seiwerth, Marija Milavic, Jaksa Vukojevic, Slaven Gojkovic, Ivan Krezic, Lovorka Batelja Vuletic, Predrag Sikiric "Stable Gastric Pentadecapeptide BPC 157 and Wound Healing"
Response: We agree with commenters that effectuating change in any size health system can be challenging